← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 16, 2017Last known activity
Jun 8, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 5 trials)
Indications
Studied for
Recent trials (5)
- NCT06097780CollaboratorPhase 3Jun 8, 2024
- NCT04315987CollaboratorPhase 1Apr 30, 2020
- NCT04219241CollaboratorPhase 2/Phase 3Jan 31, 2020
- NCT03252535CollaboratorPhase 2Apr 18, 2018
- NCT02728115CollaboratorPhase 1Oct 16, 2017
Details
- Last known activity
- Jun 8, 2024